Pfizer 20 avr. 2026 Pfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha Pfizer, Astellas win FDA priority review for Padcev (PFE:NYSE) - Seeking Alpha Original